Both in Pharmaceuticals
ZOETIS vs Insmed
Over the past year ZTS returned −28.3% and INSM returned −39.8%; their daily moves had a correlation of 0.36.
ZTS −28.3% INSM −39.8%Growth of $1, one year, split-adjusted
| Metric | ZTS | INSM |
|---|---|---|
| Price | $89.20 | $110.00 |
| Market cap | $36.86B | $24.13B |
| Today | +7.48% | +5.32% |
| 1 month | +25.1% | +4.5% |
| 6 months | −19.8% | −19.8% |
| Year to date | −29.1% | −36.8% |
| 1 year | −38.2% | −40.9% |
| Revenue growth (YoY) | −0.2% | +268.4% |
| Gross margin | 72.7% | 85.1% |
| Net margin | 28.0% | −19.1% |
| P/E (TTM) | 14.1× | — |
| Price / sales | 3.9× | 15.9× |
| Net cash | -$7.37B | $569.9M |
| Dividend yield | 2.38% | — |
| Volatility (60d) | 32.1% | 48.6% |
| Short % of float | 4.2% | 6.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).